http://orcid.org/0000-0001-6459-5996
References
- Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother. 2000;34:1373–9.
- Levinson, D. Inspector General—Adverse Events in Hospitals: National Incidence Among Medicare Beneficiaries. Department of Health and Human Services, 2010. http://oig.hhs.gov.OEI-06-09-00090
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
- Hartwig SC, Siegel J and Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Amer J Health-Syst Pharm. 1992;49(9):2229–32.
- Schumock GT, and Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538.
- Sultana J, Cutroneo P and Trifiro G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(Suppl 1):S73–S77.
- Classen DC, Pestotnik SL, Evans S, Lloyd JF and Burke JP. Adverse drug events in hospitalized patients. JAMA. 1997;277(4):301–306.
- Lahue B, Pyenson B, Iwasaki K, Blumen H, Forray S, Rothschild J. National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs. Am Health Drug Benef. 2012;5(7):1–10.
- Sharma A, Kumari KM, Manohar HS, Bairy KL, Thomas J. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India. Perspect Clin Res. 2015;6(2):109–115.
- Namazi S, Sagheb MM and Karimzadeh I. Adverse reactions of immunosuppressive drugs in Iranian adult kidney transplant recipients. Exp Clin Transp. 2012;10(3):224–31.
- Jose J and Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;54(3):226–33.
- Hug BL, Witkowski DJ, Sox CM et al. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med. 2010;25(1):31–8.
- Geer MI, Koul PA, Tanki SA and Shah MY. Frequency, types, severity, preventability and costs of adverse drug reactions at a tertiary care hospital. J Pharmacol Toxicol Meth. 2016;81:323–34.
- Khan LM. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay – a systematic review. Eur J Clin Pharmacol. 2013;69(12):1985–96.
- Alsbou M, Alzubiedi S, Alzobi H et al. Adverse drug reactions experience in a teaching hospital in Jordan. Int J Clin Pharm. 2015;37(6):1188–93.
- Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA and Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clinical Pharmacol. 2007;7(8):1–5.
- Ponnusankar S, Tejaswini M, and Chaitanya M. Assessment of adverse drug reactions based on spontaneous signals at a secondary care public hospital. Ind J Pharm Sci. 2015;77(4):490–3.
- Niedu C, Mannsaker B, Pawinski A, Haukland E. Polypharmacy in older patients ≥70 years receiving palliative radiotherapy. Anticancer Res. 2017;37(2):795–9.
- Devilla-Sanchez D, Molist-Brunet N, Amblas-Novellas J, Espaulella-Panicot J, and Codina-Jane C. Potentially inappropriate medication at hospital admission in patients with palliative care needs. Int J Clin Pharm. 2017;39(5):1018–30.
- McNeil MJ, Kamal AH, Kutner JS, Ritchie CS and Abernethy AP. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage. 2016;51(2):178–83.
- Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55(4):590–5.
- Warshaw G. Preventing adverse drug reactions. Annals of Long-term care: Clinical Care and Aging. 2014;22(4):11.
- Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, et al. Adverse drug reactions as cause of hospital admissions. J Am Geriatr Soc. 2002;50:1962–8.
- Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc. 2012;60(10):34–41.
- Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079–96.